Nadeem Qureshi at University of Nottingham - Research Interests, Publications & Academic Profile

Nadeem Qureshi

Clinical Professor

University of Nottingham

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cardiology

40%

Health Economics

60%

Hypercholesterolemia

50%

Atherosclerosis

40%

Medical Science

30%

Health Outcomes

30%

Primary Care

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Open

Lipid-modifying therapy in children with familial hypercholesterolemia

Open Date: 2023-02-01

Close Date: 2028-01-01

Grant: Close

The use of decision-support tools to improve the classification and management of patients with young-onset diabetes in primary care

Open Date: 2023-02-01

Close Date: 2025-12-01

Grant: Open

PhD Programme for Primary Care Clinicians

Open Date: 2022-10-01

Close Date: 2029-09-30

Grant: Close

A review into ethnic health inequalities in precision medicine and the future of healthcare

Open Date: 2022-07-01

Close Date: 2023-08-01

Grant: Close

A novel, artificial intelligence, approach to dementia risk prediction model development and testing in the diverse UK population

Open Date: 2022-04-01

Close Date: 2024-03-01

Articles14

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening

Article Link

Year:

2023

Association between pain intensity and depressive symptoms in community-dwelling adults: longitudinal findings from the Survey of Health, Ageing and Retirement in Europe (SHARE).

Article Link

Year:

2023

UK research data resources based on primary care electronic health records: review and summary for potential users.

Article Link

Year:

2023

Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study

Article Link

Year:

2023

Cardiovascular outcomes and mortality after incident ischaemic stroke in patients with a recent cancer history

Article Link

Year:

2023

Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care

Article Link

Year:

2023

The role of knowledge, primary care and community engagement to improve breast-screening access for Pakistani women in the United Kingdom: A secondary analysis of a qualitative study

Article Link

Year:

2023

UK research data resources based on primary care electronic health records: review and summary for potential users

Article Link

Year:

2023

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis

Article Link

Year:

2023

Determinants of lipid clinic referral and attendance in a multi-ethnic adult population in south London: a cross-sectional study.

Article Link

Year:

2023

A population-based study exploring phenotypic clusters and clinical outcomes in stroke using unsupervised machine learning approach.

Article Link

Year:

2023

Electronic health record-based facilitation of familial hypercholesterolaemia detection sensitivity of different algorithms in genetically confirmed patients

Article Link

Year:

2022

Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial.

Article Link

Year:

2022

How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis.

Article Link

Year:

2022

Collaborators21

Stuart Wright

The University of Manchester

UNITED KINGDOM

Vicky Booth

Assistant Professor

University of Nottingham

UNITED KINGDOM

Elaine Harkness

The University of Manchester

UNITED KINGDOM

Louise Gorman

The University of Manchester

UNITED KINGDOM

Anthony Howell

The University of Manchester

UNITED KINGDOM

Darren Ashcroft

The University of Manchester

UNITED KINGDOM

Irene Petersen

Aarhus University

DENMARK

Bethan Sarah Woods

University of York

UNITED KINGDOM

Stephen Duffy

Professor of Cancer SCreening

Queen Mary University of London

UNITED KINGDOM

jan cornel

Professor

Radboud University Medical Center

NETHERLANDS

Azeem Majeed

Imperial College London

UNITED KINGDOM

Roelof Smit

Københavns Universitet

DENMARK

Gareth Evans

The University of Manchester

UNITED KINGDOM

Barbara Iyen

NIHR Clinical Assistant Professor/ Academic clinical lecturer

University of Nottingham

UNITED KINGDOM

Christian D Mallen

Keele University

UNITED KINGDOM

Jemima T Collins

UNITED KINGDOM

Lorna McWilliams

The University of Manchester

UNITED KINGDOM

Victoria Grace Woof

The University of Manchester

UNITED KINGDOM

michelle harvie

UNITED KINGDOM

Adam Brentnall

Queen Mary University of London

UNITED KINGDOM

Katherine Payne

The University of Manchester

UNITED KINGDOM

How do Indian students reach out?

Meet Kite AI